CDH1 and neoplasm: To further determine whether E-cadherin + DCs enhanced the antitumour activity and prolonged the survival time of tumour-bearing mice, we monitored tumour growth and the survival time of the subcutaneous model, as well as the survival time for the orthotopic lung tumour model (Figure 5A-C).